Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tabea Erdmann

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Blood|October 14, 2018
Temporal autoregulation during human PU.1 locus SubTAD formationDaniel Schuetzmann, Carolin Walter, Boet van Riel, et al.
Leukemia|January 5, 2023
Molecular profiling of EBV associated diffuse large B-cell lymphomaFabian Frontzek, Annette M Staiger, Ramona Wullenkord, et al.
Blood|November 1, 2014
Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphomaAndre Weilemann, Michael Grau, Tabea Erdmann, et al.
Blood|February 17, 2017
Sensitivity to PI3K and AKT inhibitors is mediated by divergent molecular mechanisms in subtypes of DLBCLTabea Erdmann, Pavel Klener, James T Lynch, et al.
Blood|November 20, 2016
B-cell receptor-driven MALT1 activity regulates MYC signaling in mantle cell lymphomaBeiying Dai, Michael Grau, Mélanie Juilland, et al.
Molecular Cancer Therapeutics|October 21, 2020
Selective Vulnerability to Pyrimidine Starvation in Hematologic Malignancies Revealed by AG-636, a Novel Clinical-Stage Inhibitor of Dihydroorotate DehydrogenaseGabrielle McDonald, Victor Chubukov, John Coco, et al.
Nature Communications|July 6, 2022
Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to ageBirgit Burkhardt, Ulf Michgehl, Jonas Rohde, et al.
Nature Communications|September 1, 2021
Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphomaFabian Frontzek, Annette M Staiger, Myroslav Zapukhlyak, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Blood|October 14, 2018
Temporal autoregulation during human PU.1 locus SubTAD formationDaniel Schuetzmann, Carolin Walter, Boet van Riel, et al.
Leukemia|January 5, 2023
Molecular profiling of EBV associated diffuse large B-cell lymphomaFabian Frontzek, Annette M Staiger, Ramona Wullenkord, et al.
Blood|November 1, 2014
Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphomaAndre Weilemann, Michael Grau, Tabea Erdmann, et al.
Blood|February 17, 2017
Sensitivity to PI3K and AKT inhibitors is mediated by divergent molecular mechanisms in subtypes of DLBCLTabea Erdmann, Pavel Klener, James T Lynch, et al.
Blood|November 20, 2016
B-cell receptor-driven MALT1 activity regulates MYC signaling in mantle cell lymphomaBeiying Dai, Michael Grau, Mélanie Juilland, et al.
Molecular Cancer Therapeutics|October 21, 2020
Selective Vulnerability to Pyrimidine Starvation in Hematologic Malignancies Revealed by AG-636, a Novel Clinical-Stage Inhibitor of Dihydroorotate DehydrogenaseGabrielle McDonald, Victor Chubukov, John Coco, et al.
Nature Communications|July 6, 2022
Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to ageBirgit Burkhardt, Ulf Michgehl, Jonas Rohde, et al.
Nature Communications|September 1, 2021
Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphomaFabian Frontzek, Annette M Staiger, Myroslav Zapukhlyak, et al.
Pageof 2